8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001517022-26-000071 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Directly affected
- AKBA Akebia Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001517022-26-000071 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Source: sec-edgar
Akebia Therapeutics (AKBA) since “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer),” compared with the market
Since the first closing price after “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer),” Akebia Therapeutics (AKBA) is -1.58%. The S&P 500 fund (SPY) is -0.67% over the same days, a -0.91% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Akebia Therapeutics (AKBA) | that day | -8.85% | final price |
| Akebia Therapeutics (AKBA) | the next day | -10.26% | final price |
| Akebia Therapeutics (AKBA) | two days later | -12.91% | final price |
| Akebia Therapeutics (AKBA) | three days later | -11.67% | final price |
| Akebia Therapeutics (AKBA) | three days earlier | +5.57% | final price |
| Akebia Therapeutics (AKBA) | five days earlier | +13.57% | final price |
| GLD | that day | -1.49% | final price |
| GLD | the next day | +0.27% | final price |
| GLD | two days later | +0.10% | final price |
| GLD | three days later | -0.52% | final price |
| GLD | three days earlier | +0.77% | final price |
| GLD | five days earlier | -1.52% | final price |
| QQQ | that day | -1.97% | final price |
| QQQ | the next day | -2.08% | final price |
| QQQ | two days later | -4.55% | final price |
| QQQ | three days later | -3.41% | final price |
| QQQ | three days earlier | +1.02% | final price |
| QQQ | five days earlier | +1.90% | final price |
| SPY | that day | -1.08% | final price |
| SPY | the next day | -0.80% | final price |
| SPY | two days later | -1.89% | final price |
| SPY | three days later | -1.47% | final price |
| SPY | three days earlier | +0.06% | final price |
| SPY | five days earlier | -0.11% | final price |
| TLT | that day | +0.68% | final price |
| TLT | the next day | +2.09% | final price |
| TLT | two days later | +2.15% | final price |
| TLT | three days later | +1.42% | final price |
| TLT | three days earlier | -0.50% | final price |
| TLT | five days earlier | -1.52% | final price |
Who is named in “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)”
Companies tied to this story
- AKBA Akebia Therapeutics
In “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer),” Akebia Therapeutics (AKBA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AKBA
How “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)” reaches Akebia Therapeutics (AKBA)
Akebia Therapeutics (AKBA) is the company in “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer),” the 14 Oct 2026 this story story.
Akebia Therapeutics (AKBA) is on the page because SEC 8-K filing -> direct issuer disclosure -> AKBA
Dates in the story, and the Akebia Therapeutics (AKBA) price range
AKBA traded between 0.67 and 1.04 across 15 sessions. The latest close on file is 0.68.
What the saved facts support for Akebia Therapeutics (AKBA)
44 out of 100
“8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)” scores 44 out of 100. The score uses 1 sources, a -9.46% difference versus the S&P 500 (SPY), and 1 linked companies.